LENSAR, Inc. (LNSR) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, LENSAR reported revenue of $58.4M, up 9.2% from $53.5M the year before. Net income was -$34.3M (a -58.7% net margin), or -$2.87 per diluted share. Gross margin was 46.4% and operating margin was -42.1%. Operating activities generated -$14.8M of cash, leaving -$14.9M of free cash flow. At fiscal year end, LENSAR held $71.4M in total assets against $83.7M in total liabilities, including $13.0M of cash and equivalents.
Open the full interactive LENSAR financials → Quarterly statements, key ratios, valuation history and price charts.
LENSAR Key Stats
| Share Price | $6.27 |
|---|---|
| Market Cap | $144.4M |
| Revenue YoY Growth | +9.2% |
| 52-Week Range | $5.01 – $12.73 |
| Shares Outstanding | 12.3 million (basic, 2026 Q2) |
LENSAR Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $26.4M | $34.5M | $35.4M | $42.2M | $53.5M | $58.4M |
| Gross Profit | $14.1M | $17.8M | $20.0M | $21.1M | $25.9M | $27.1M |
| Operating Income | -$18.5M | -$19.7M | -$20.2M | -$12.2M | -$10.7M | -$24.6M |
| Pre-Tax Income | -$19.8M | -$19.6M | -$19.9M | -$14.4M | -$31.4M | -$34.3M |
| Net Income | -$19.8M | -$19.6M | -$19.9M | -$14.4M | -$31.4M | -$34.3M |
| Diluted EPS | -$4.28 | -$2.09 | -$1.96 | -$1.31 | -$2.73 | -$2.87 |
LENSAR Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $14.3M | $16.0M | $13.4M | $16.5M |
| Net Income | -$3.7M | -$1.5M | $36.3M | $3.5M |
| Diluted EPS | -$0.31 | -$0.12 | — | $0.10 |
LENSAR Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $40.6M | $31.6M | $14.7M | $20.6M | $16.3M | $13.0M |
| Current Assets | $58.4M | $44.8M | $33.7M | $46.4M | $42.0M | $46.8M |
| Total Assets | $79.1M | $66.5M | $55.8M | $69.6M | $66.3M | $71.4M |
| Current Liabilities | $8.5M | $8.7M | $11.4M | $11.6M | $15.0M | $40.6M |
| Total Liabilities | $11.9M | $11.6M | $13.9M | $22.4M | $47.7M | $83.7M |
| Shareholders' Equity | $67.2M | $54.9M | $42.0M | $33.4M | $4.9M | -$26.0M |
LENSAR Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$13.8M | -$9.0M | -$14.9M | -$9.7M | -$2.3M | -$14.8M |
| Cash From Investing | -$326,000 | -$354,000 | -$115,000 | -$4.2M | -$2.2M | $1.3M |
| Cash From Financing | $50.0M | $361,000 | -$2.0M | $19.8M | $78,000 | $10.3M |
| Free Cash Flow | -$14.2M | -$9.3M | -$15.0M | -$9.9M | -$2.4M | -$14.9M |
Figures from LENSAR's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full LENSAR financials page for every line item.
LENSAR Company Profile
| Ticker | LNSR |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Orlando, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001320350 |
Frequently Asked Questions
What was LENSAR's revenue in fiscal 2025?
LENSAR (LNSR) reported revenue of $58.4M for fiscal 2025.
What is LENSAR's annual revenue history?
LENSAR's annual revenue by fiscal year: 2020: $26.4M; 2021: $34.5M; 2022: $35.4M; 2023: $42.2M; 2024: $53.5M; 2025: $58.4M.
What was LENSAR's net income in fiscal 2025?
LENSAR reported net income of -$34.3M for fiscal 2025.
What was LENSAR's earnings per share (EPS) in fiscal 2025?
LENSAR's diluted EPS was -$2.87 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did LENSAR generate in fiscal 2025?
LENSAR generated -$14.9M of free cash flow in fiscal 2025.
What was LENSAR's revenue last quarter?
In its most recent reported quarter (2026 Q2), LENSAR reported revenue of $16.5M.
How many shares of LENSAR are outstanding?
LENSAR reported a weighted average of 12.3 million basic shares outstanding in 2026 Q2.
What is LENSAR's market cap?
Based on its latest closing price, LENSAR (LNSR) has a market capitalization of about $144.4M.
When does LENSAR's fiscal year end?
LENSAR's fiscal year end, as registered with the SEC, is December 31.
Where is LENSAR headquartered?
LENSAR lists its business address in Orlando, Florida in its SEC filings.
LENSAR Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →